INVO Fertility, Inc. SEC filings IVF
INVO Fertility, Inc. has 596 filings in SEC EDGAR's recent list, going back to Nov 13, 2007. Its latest annual report, Form 10-K, was filed on Jun 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (bylaw or fiscal year change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 4, 2026 | — |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Feb 10, 2026 | — |
| CORRESP | Letter to the SEC | Feb 6, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| NT 10-Q | Filing | Nov 17, 2025 | Sep 30, 2025 |
| NT 10-Q | Filing | May 15, 2025 | Mar 31, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| DEFR14A | Filing | Mar 12, 2025 | — |
| EFFECT | Filing | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 8, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2024 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 21, 2024 | — |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| RW | Filing | Oct 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| CORRESP | Letter to the SEC | Jul 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| CORRESP | Letter to the SEC | Jul 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2024 | — |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| SC TO-C | Filing | Nov 13, 2023 | — |
| EFFECT | Filing | Aug 3, 2023 | — |
| CORRESP | Letter to the SEC | Aug 2, 2023 | — |
| CORRESP | Letter to the SEC | Aug 2, 2023 | — |
| CORRESP | Letter to the SEC | Jul 24, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| EFFECT | Filing | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 5, 2023 | — |
| D | Filing | Apr 6, 2023 | — |
| NT 10-K | Filing | Mar 30, 2023 | Dec 31, 2022 |
| D/A | Filing | Mar 6, 2023 | — |
| D | Filing | Feb 17, 2023 | — |
| D | Filing | Jan 11, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2021 | — |
| CORRESP | Letter to the SEC | Jun 17, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2021 | — |
| EFFECT | Filing | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Apr 14, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| CORRESP | Letter to the SEC | Apr 7, 2021 | — |
| POS EX | Form pos ex | Nov 13, 2020 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| CERT | Filing | Nov 12, 2020 | — |
| 8-A12B | Form 8-a12b | Nov 12, 2020 | — |
| CORRESP | Letter to the SEC | Nov 9, 2020 | — |
| CORRESP | Letter to the SEC | Nov 9, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2020 | — |
| CORRESP | Letter to the SEC | Sep 21, 2020 | — |
| EFFECT | Filing | Jul 15, 2020 | — |
| D/A | Filing | Jul 15, 2020 | — |
| CORRESP | Letter to the SEC | Jul 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| D | Filing | May 28, 2020 | — |
| EFFECT | Filing | Sep 16, 2019 | — |
| CORRESP | Letter to the SEC | Sep 12, 2019 | — |
| 8-A12G | Form 8-a12g | Sep 9, 2019 | — |
| NT 10-K | Form nt 10-k | Apr 1, 2019 | Dec 31, 2018 |
| UPLOAD | Letter from the SEC | Dec 26, 2018 | — |
| D | Filing | Jan 24, 2018 | — |
| NT 10-K | Filing | Mar 31, 2017 | Dec 31, 2016 |
| NT 10-K | Filing | Mar 30, 2012 | Dec 31, 2011 |
| NT 10-Q | Filing | Nov 14, 2011 | Sep 30, 2011 |
| NT 10-Q | Filing | Aug 15, 2011 | Jun 30, 2011 |
| NT 10-Q | Filing | May 16, 2011 | Mar 31, 2011 |
| NT 10-K | Filing | Mar 31, 2011 | Dec 31, 2010 |
| NT 10-Q | Filing | Nov 16, 2010 | Sep 30, 2010 |
| NT 10-Q | Filing | Aug 16, 2010 | Jun 30, 2010 |
| EFFECT | Filing | Aug 2, 2010 | — |
| NT 10-K | Filing | Mar 31, 2010 | Dec 31, 2009 |
| EFFECT | Filing | Dec 30, 2009 | — |
| D | Filing | Oct 14, 2009 | — |
| NT 10-K | Filing | Mar 31, 2009 | Dec 31, 2008 |
| UPLOAD | Letter from the SEC | Mar 20, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2009 | — |
| CORRESP | Letter to the SEC | Mar 19, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2009 | — |
| CORRESP | Letter to the SEC | Feb 17, 2009 | — |
| 10KSB | Filing | Mar 26, 2008 | Dec 31, 2007 |
| EFFECT | Filing | Jan 30, 2008 | — |
| SB-2/A | Filing | Jan 25, 2008 | — |
| SB-2 | Filing | Nov 13, 2007 | — |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.